Law, Politics, and Expert Panels at the US Food and Drug Administration

This Viewpoint discusses the lawfulness and credibility of the US Food and Drug Administration’s recent move to using expert panels rather than advisory committees for decision-making.

Authors

Institutions

Publication Details

Journal
JAMA Health Forum
Published
2026-02-13
DOI
https://doi.org/10.1001/jamahealthforum.2025.6812
Citations
1
Primary Topic
Ethics in Clinical Research
Type
article
Field-Weighted Citation Impact
41.85
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Law, Politics, and Expert Panels at the US Food and Drug Administration

Aaron S. Kesselheim, C. Joseph Ross Daval
1 citations
JAMA Health Forum
Ethics in Clinical Research
41.85
article

Law, Politics, and Expert Panels at the US Food and Drug Administration

Aaron S. Kesselheim, C. Joseph Ross Daval
article en
1 citations

Abstract

This Viewpoint discusses the lawfulness and credibility of the US Food and Drug Administration’s recent move to using expert panels rather than advisory committees for decision-making.

JAMA Health ForumVol. 7(2)
Brigham and Women's Hospital (US), Harvard University (US)
Peace, Justice and strong institutions
Openalex Percentile: Top 1%
Ethics in Clinical Research
41.85
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Law, Politics, and Expert Panels at the US Food and Drug Administration — Aaron S. Kesselheim, C. Joseph Ross Daval · JAMA Health Forum (2026) | TGRS Research Map | TGRS